Iranian Journal of Microbiology 2016. 8(5):321-325.

Distribution of hepatitis C virus genotypes in Arak city, central province of Iran
Masoomeh Sofian, Amitis Ramezani, Hossein Imani, Ali-Asghar Farazi, Mohammad Banifazl, Ali jourabchi, Arezoo Aghakhani

Abstract


Background and Objectives: Hepatitis C virus (HCV) infection is a worldwide concern and it is the major cause of liver disease. Several genotypes of the HCV have been reported from different regions of the world. The determination of the HCV genotypes is important for the prediction of response to antiviral treatment and clinical outcomes. So, HCV genotyping in each region is of great importance. This investigation was performed to determine the distribution of HCV genotypes in Arak city, Central province of Iran.

Patients & Methods: In this cross sectional study, 174 cases with chronic HCV infection from Arak city were enrolled. HCV infection was confirmed by positive results in HCV antibody (anti-HCV) and HCV-RNA tests. HCV genotypes were determined using a PCR based genotyping kit.

Results: A total of 174 HCV infected patients with mean age of 37.5±10.24 years were enrolled. 97.7% of cases were male and 2.3% were female. The main route of HCV transmission was injection drug use (IDU) which was observed in 59.8% of cases. Genotyping results demonstrated that subtype 3a (52.9%) was the most prevalent HCV type in Arak, followed by subtype 1a (22.9%) and subtype 1ab (17.8%).

Conclusion: This study showed that HCV subtype 3a was the most prevalent HCV type, followed by subtype 1a and subtype 1ab in Arak, central province of Iran. Investigation of HCV genotypes in different parts of the country is needed to facilitate treatment options and preventive strategies.

Keywords: Hepatitis C virus (HCV), Genotype, Arak, Iran


Keywords


Hepatitis C virus (HCV); Genotype, Arak, Iran

Full Text:

PDF

References


Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-567.

Brown RS, Jr, Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl 2003; 9:S10–S13.

Alavian SM. We need a new national approach to con-trol hepatitis C: It is becoming too late. Hepat Mon 2008; 8:165–169.

Daw MA, Dau AA, Agnan MM. Influence of health- care-associated factors on the efficacy of hepatitis C therapy. Scientific World Journal 2012; 2012:580216.

Szabo SM, Bibby M, Yuan Y, Donato BM, Castañe- da-Hernández G, et al. The epidemiologic burden of hepatitis C virus infection in Latin America. Ann Hepatol 2012;11:623–635.

Chayama K, Hayes CN. Hepatitis C virus: How genetic variability affects pathobiology of disease. J Gastroen- terol Hepatol 2011; 26 Suppl 1:83-95.

Chevaliez S, Pawlotsky JM. Hepatitis C virus: virol- ogy, diagnosis and management of antiviral therapy. World J Gastroenterol 2007; 13:2461-2466.

El-Shamy A, Hotta H. Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.World J Gastroenterol 2014; 20:7555-7569.

Wang Y. Scotomas in molecular virology and epidemi-ology of hepatitis C virus. World J Gastroenterol 2013;19:7910-7921.

Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995; 15:41-63.

Simmonds P. Genetic diversity and evolution of hepati- tis C virus-15 years on. J Gen Virol 2004; 85:3173-3188.

Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the Unit- ed States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125:634–639.

Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann In- tern Med 1995; 122:161-168.

Ramia S, Eid-Fares J. Distribution of hepatitis C virusgenotypes in the Middle East. Int J Infect Dis 2006;10:272-277.

Simmonds P. Genetic diversity and evolution of hep- atitis C virus-15 years on. J Gen Virol 2004; 85(Pt11):3173–88.

Khan N, Akmal M, Hayat M, Umar M, Ullah A, Ahmed I, et al. Geographic distribution of hepatitis C virus genotypes in Pakistan. Hepat Mon 2014;14(10):e20299.

Esmaeilzadeh A, Erfanmanesh M, Ghasemi S, Mo- hammadi F. Serological assay and genotyping of hep- atitis C virus in infected patients in Zanjan province. Hepat Mon 2014;14(9):e17323

Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic analysis of hepatitis C virus in Khuzestan province, southwestern Iran. Middle East J Dig Dis 2011; 3(2):126-130.

Mousavi SF, Moosavy SH, Alavian SM, Eghbali H, Mahboobi H. Distribution of hepatitis C virus geno- types among patients with hepatitis C virus infection in hormozgan, iran. Hepat Mon 2013;13(12):e14324.

Rastin M, Mahmoudi M, Rezaee SA, Assarehzadegan MA, Tabasi N, Zamani S, et al. Distribution of Hepati- tis C virus genotypes in city of Mashhad, North-east of Iran. Indian J Med Microbiol 2014; 32:53-56.

Rosen HR, Martin P. Viral hepatitis in the liver trans-plant recipient. Infect Dis Clin North Am 2000;14:761-784.

Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, Rasachak B, et al. Genetic history of hepatitis C virus in East Asia. J Virol 2009; 83:1071-1082.

Hajia M, Amirzargar A, Khedmat H, Shahrokhi N,Farzanehkhah M, Ghorishi S, et al. Genotyping pattern among Iranian HCV positive patients. Iran J Public Health 2010; 39:39-44.

Khodabandehloo M, Roshani D. Prevalence of hepa- titis C virus genotypes in Iranian patients: a system- atic review and meta-analysis. Hepat Mon 2014 Dec;14(12): e22915.

Omrani MD, Khadem Ansari MH. Hepatitis C Virus Genotyping by Melting Curve Analysis in West Azer- baijan, Northwest of Iran. Hepat Mon 2009;9(2):33-136

Ziyaeyan M, Alborzi A, Jamalidoust M, Badiee P, Moeini M, Kadivar A. Prevalence of hepatitis C virus genotypes in chronic infected patients, southern Iran. Jundishapur J Microbiol 2011; 4:141–146.

Ashrafi Hafez A, Baharlou R, Mousavi Nasab SD, Ahmadi Vasmehjani A, Shayestehpour M, Joharin- ia N, et al. Molecular epidemiology of different hep- atitis C genotypes in serum and peripheral blood mononuclear cells in jahrom city of iran. Hepat Mon 2014;14(5):e16391

Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Ka- zemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis pa- tients in Tehran-a multicenter study. J Med Virol 2006;78:569–573.

Afshari R, Nomani H, Zaniani FR, Nabavinia MS, Mirbagheri Z, Meshkat M, et al. Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. Turk J Med Sci 2014; 44:656-660.

Farivar TN, Nezam MK, Johari P. Genotyping of hep- atitis C virus isolated from hepatitis patients in South- east of Iran by Taqman Realtime PCR. J Pak Med As- soc 2011; 61:586-588.

Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Ala- vian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon 2013 Jan;13(1):e7991.

Salehi Moghadam F, Mohebbi SR, Hosseini SM, Ro- mani S, Mirtalebi H, Azimzadeh P, et al. Phylogenetic analysis of hepatitis C virus strains and risk factors as- sociated with infection and viral subtypes among Ira- nian patients. J Med Virol 2014; 86:1342-1349.

Hadinedoushan H, Salmanroghani H, Amirbaigy MK, Akhondi-Meybodi M. Hepatitis C virus genotypes and association with viral load in yazd, central province of iran. Hepat Mon 2014; 14(3):e11705.

Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, et al. Hepatitis C virus genotypes distribu- tion and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol 2008;14(8):1237-1243.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.